logo

Biomedical Advanced Research And Development Authority (Barda) Broad Agency Announcement (Baa)

Sector: Government • Location: United States of America

Source: SAM.gov

Tender
Award Notice

The Pandemic and All Hazards Preparedness Act (PAHPA) of 2006 established the Center for the Biomedical Advanced Research and Development Authority (BARDA) and was reauthorized under the PAHPA of 2013 and again in 2019 under the Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAIA), Public Law No. 116-22, to support development and acquisition of medical countermeasure (MCMs

Status
Closed
Sector
Government, Chemical (Industrial), Nuclear, Commercial, Residential, Manufacturing (Industrial), Hospital
Location
United States of America
Updated
3 Nov 2026
Source
SAM.gov

ConstructChat

Ask ConstructChat about Biomedical Advanced Research And Development Authority (Barda) Broad Agency Announcement (Baa)

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

4 Q
The tender “Biomedical Advanced Research And Development Authority (Barda) Broad Agency Announcement (Baa)” is a tender record in Taiyo, linked to the Government sector. It is issued for works, goods, or services related to United States of America.

Participants

Not available for this record.

Status

Original status

award notice

Taiyo status

Closed

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

The Pandemic and All Hazards Preparedness Act (PAHPA) of 2006 established the Center for the Biomedical Advanced Research and Development Authority (BARDA) and was reauthorized under the PAHPA of 2013 and again in 2019 under the Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAIA), Public Law No. 116-22, to support development and acquisition of medical countermeasure (MCMs) to prevent or treat the medical consequences of chemical, biological, radiological, and nuclear (CBRN) threats, pandemic influenza (PI), and emerging infectious diseases (EID). These MCMs include vaccines, therapeutics, diagnostics, and medical devices. Additionally, BARDA is entrusted to foster innovation of technologies that enable better manufacturing, testing, and utilization of these medical countermeasures. The overall objective of this contract is to advance the development of FloPatch FP120 with FloPredict Alert for Burn and Blast Medical Countermeasure. The scope of work for this contract includes clinical and product development activities that fall into the following areas: clinical studies, algorithms, hardware and software development, and all associated regulatory, quality assurance, management, and administrative activities. The Government has determined a Bona Fide Need for each non-severable discrete work segment which will conclude upon the completion of a defined tasks that provide(s) independent merit and value to the Government. The Contractor's success in completing the required tasks under the work segments must be demonstrated through the Deliverables and Milestones specified under Article F of this contract. As set forth in Attachment 1, Statement of Work, the Go/No-Go, Deliverable, and/or Milestone will constitute the basis for the Government’s decision, at its sole discretion, to exercise any follow-on option period(s).

Original sector

Professional, Scientific, and Technical Services

Budget

Location

Country

United States of America (USA)

Source

Source

SAM.gov

URL

More Details

Record type

Tender

Sector

Government, Chemical (Industrial), Nuclear, Commercial, Residential, Manufacturing (Industrial), Hospital

Article published date

2026-06-06

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender